Isryl-M 3 Tablet PR: A Balanced Approach to Blood Sugar Control

Isryl-M 3 Tablet PR is a combined oral medication formulated with Glimepiride (3mg) and Metformin (500mg), offering a balanced approach for managing type 2 diabetes. This formulation works synergistically to regulate blood glucose levels effectively.

How it Works:

* Glimepiride: Primarily acts by stimulating insulin release from the pancreas, improving blood sugar control in people with impaired insulin secretion.
* Metformin: Reduces hepatic glucose production and enhances peripheral glucose uptake, contributing to overall lowering of blood sugar levels.

Benefits:

Isryl-M 3 Tablet PR helps:

* Control blood sugar levels effectively.
* Improve glycemic control for individuals with type 2 diabetes.
* Support healthy weight management.

Administration:

These tablets are taken orally, one tablet daily. The "PR" designation indicates the medication should be taken in the evening before bedtime. Always follow your healthcare provider's instructions and any prescribed dosage adjustments.

Note: This description provides general information only. Consult with a doctor for personalized treatment and individual needs.